中文名称: | BI-749327 | ||||
---|---|---|---|---|---|
英文名称: | BI-749327 | ||||
别名: | BI-749327 [4-(6-aminopyridazin-3-yl)piperidin-1-yl]-[4-[4-(trifluoromethyl)phenoxy]phenyl]methanone | ||||
CAS No: | 2361241-23-6 | 分子式: | C23H21F3N4O2 | 分子量: | 442.43 |
CAS No: | 2361241-23-6 | ||||
分子式: | C23H21F3N4O2 | ||||
分子量: | 442.43 |
基本信息
产品编号: |
B11351 |
||||
产品名称: |
BI-749327 |
||||
CAS: |
2361241-23-6 |
储存条件 |
粉末 |
-20℃ |
四年 |
|
|
||||
分子式: |
溶于液体 |
-80℃ |
6个月 |
||
分子量: |
442.43 |
-20℃ |
1个月 |
||
化学名: |
[4-(6-aminopyridazin-3-yl)piperidin-1-yl]-[4-[4-(trifluoromethyl)phenoxy]phenyl]methanone |
||||
Solubility (25°C): |
|||||
体外:
|
DMSO |
|
|||
Ethanol |
'mg/mL |
||||
Water |
|
||||
体内(现配现用): |
请根据您的实验动物和给药⽅式选择适当的溶解⽅案。以下溶解⽅案都请先按照In Vitro⽅式配制澄清的储备液,再依次添加助溶剂:为保证实验结果的可靠性,澄清的储备液可以根据储存条件,适当保存;体内实验的⼯作液,建议您现⽤现配,当天使⽤;以下溶剂前显⽰的百分⽐是指该溶剂在您配制终溶液中的体积占⽐;如在配制过程中出现沉淀、析出现象,可以通过加热和/或超声的⽅式助溶。 1.请依序添加每种溶剂:10% DMSO→40% PEG300→5% Tween-80→45% saline Solubility:≥2.08mg/mL(4.70mM);Clear solution 2.请依序添加每种溶剂:10% DMSO→90% (20% SBE-β-CD in saline) Solubility:≥2.08mg/mL(4.70mM);Clear solution 3.请依序添加每种溶剂:10% DMSO→90% corn oil Solubility:≥2.08mg/mL(4.70mM);Clear solution |
||||
<1mg/ml表示微溶或不溶。 |
|||||
普西唐提供的所有化合物浓度为内部测试所得,实际溶液度可能与公布值有所偏差,属于正常的批间细微差异现象。 |
|||||
请根据产品在不同溶剂中的溶解度选择合适的溶剂配制储备液;⼀旦配成溶液,请分装保存,避免反复冻融造成的产品失效。 |
制备储备液
浓度
溶液体积 质量 |
1mg |
5mg |
10mg |
1mM |
2.2602mL |
11.3012mL |
22.6024mL |
5mM |
0.4520mL |
2.2602mL |
4.5205mL |
10mM |
0.2260mL |
1.1301mL |
2.2602mL |
生物活性
产品描述 |
一种高效、高选择性、有口服生物活性的TRPC6拮抗剂, |
|
靶点 |
IC50:13nM (mouse TRPC6),19nM (human TRPC6),15nM (guinea pig TRPC6) |
|
体外研究 |
BI-749327 suppresses NFAT activation in HEK293T cells expressing wild-type or gain-of-function TRPC6 mutants and blocks associated signaling and expression of prohypertrophic genes in isolated myocytes. |
|
体内研究 |
BI-749327 (30mg/kg/day;i.g.) improves left heart function,reduces volume/mass ratio,and blunts expression of profibrotic genes and interstitial fibrosis in mice subjected to sustained pressure overload.BI-749327 dose dependently reduces renal fibrosis and associated gene expression in mice with unilateral ureteral obstruction.BI-749327 has long terminal half-life (t1/2 8.5-13.5 hours) for mice (3-30mg/kg;p.o.). |
|
Animal Model: |
C57BL/6J mice |
|
Dosage: |
30mg/kg/day |
|
Administration: |
Oral gavage |
|
Result: |
Improved left heart function,reduced volume/mass ratio,and blunted expression of profibrotic genes and interstitial fibrosis in mice subjected to sustained pressure overload. |
|
|
||
Animal Model: |
CD-1 mice |
|
Dosage: |
3mg/kg,10mg/kg,30mg/kg |
|
Administration: |
Oral administration |
|
Result: |
t1/2 8.5-13.5 hours |
本计算器可帮助您计算出特定溶液中溶质的质量、溶液浓度和体积之间的关系,公式为:
质量 (g) = 浓度 (mol/L) x 体积 (L) x 分子量 (g/mol)
摩尔浓度计算公式
用本工具协助配置特定浓度的溶液,使用的计算公式为:
开始浓度 x 开始体积 = 最终浓度 x 最终体积
稀释公式
稀释公式一般简略地表示为:C1V1 = C2V2 ( 输入 输出 )